Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…
NCT00004094 · National Cancer Institute (NCI), NIH · Unknown status
Key facts
| NCT number | NCT00004094 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx |
| Official title | A Phase II Study of Induction Chemotherapy Followed by Concomitant Paclitaxel (1 Hour Infusion), Fluorouracil, Hydroxyurea and Hyperfractionated Radiotherapy for Advanced Oral, Pharynx and Larynx Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carboplatin, fluorouracil, hydroxyurea, paclitaxel, conventional surgery, radiation therapy |
| Start date | Aug 1, 1999 |
| First posted | May 8, 2003 |
| Last update posted | Jan 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: